- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
1997–2021 · program · P30
Program 15: Cancer Cell Biology
Jeffrey W Harper · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Biology and targeting of mutant STAG2-mediated R loop accumulation
Zuzana Tothova · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 13: Health Communication
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 03 Prostate Cancer
Steven P. Balk · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Single Cell Core
Mandovi Chatterjee · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Mouse Engineering Core
Arlene H. Sharpe · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 52: Kidney Cancer
David Mcdermott · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 1: Breast Cancer
Eric P Winer · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 12: Developmental Therapeutics
Geoffrey I Shapiro · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Core 01: Cancer Pharmacology
Jeffrey G Supko · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 11 Cancer Immunology
Arlene H. Sharpe · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Developmental Funds
Peter M Howley · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Clinical Shared Resource
Daniel J Deangelo · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 08 Cancer Data Sciences
Franziska Michor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 15: Cancer Cell Biology
Jeffrey W Harper · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Protocol Review and Monitoring System
Laurie Hollis Glimcher · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 14: Survey and Data Management
Wendy Beth London · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P01
Biostatistics Core
Donna S. Neuberg · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Tissue Microarray and Imaging Core
Sabina Signoretti · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P01
Directing AML therapy with BH3 profiling
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 3: Prostate Cancer
Steven P. Balk · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 02: Gynecologic Cancers
Ursula Anne Matulonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 7: Cancer Epidemiology
Lorelei Mucci · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 09 Cancer Genetics
Eliezer M Van Allen · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 03 Prostate Cancer
Steven P. Balk · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Administrative Core
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 12: Developmental Therapeutics
Geoffrey I Shapiro · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 05: Collaborative Functional Genomics
Stephanie E Mohr · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Core 03: Tumor Imaging Metrics
Gordon J Harris · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 01 Breast Cancer
Eric P Winer · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Clinical Protocol and Data Management
Jeffrey A Meyerhardt · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Shared Resource 16: Research Pharmacy
Sylvia Bartel · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 06 Lymphoma and Myeloma
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Protocol Review and Monitoring System
Jeffrey A Meyerhardt · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Shared Resource Management
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Developmental Funds
Peter M Howley · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2026 · program · P30
Program 06 Lymphoma and Myeloma
Irene M. Ghobrial · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2025 · program · P01
Directing AML therapy with BH3 profiling
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2021 · program · P30
Program 8: Cancer Data Sciences
Franziska Michor · Dana-Farber Cancer Institute · funded by National Institutes of Health
1997–2030 · program · P01
Targeting BFL-1 in Acute Myelogenous Leukemia
Anthony G Letai · Dana-Farber Cancer Institute · funded by National Institutes of Health
